|
MacKay HJ, Hoekstra R, Eskens FALM, Loos WJ, Crawford D, Voi M, Van Vreckem A, Evans TRJ, Verweij J. A phase I pharmacokinetic and pharmacodynamic study of the farnesyl transfesrase inhibitor BMS-214662 in combination with cisplatin in patients with advanced solid tumors
Clinical Cancer Research
Jodrell DI, Evans TRJ, Steward W, Cameron D, Prediville J, Aschele C, Noberasco C, Lind M, Carmichael J, Dobbs N, Camboni G, Gatti B, DeBraud F. Phase II studies with BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
European Journal of Cancer
Bisland AE, Anderson C, Fletcher-Monaghan AJ, McGregor F, Evans TRJ, Ganly I, Knox RJ, Plumb JA, Keith WN. Selection ablation of human cancer cells by telomerase-specific adenoviral gene therapy vectors expressing bacterial nitorductase
Oncogene
Diaz-Rubio E, Evans TRJ, Tabernero J, Cassidy J, Sastre J, Eatock M, Bisset D, Regueiro P, Baselga J. Capecitabine (Xeloda) in combination with oxaliplatin: a phase 1, dose-escalation study in patients with advanced or metastatic solid tumors
Annals of Oncology
Evans TRJ, Colston KW, Lofts FJ, Cunningham D, Anthoney DA, Gogas H, DeBono JS, Hamberg KJ, Skov T, Mansi JL. A phase II trial of the vitamin D analogue Seocalcitol (EB 1089) in patients with inoperable pancreatic cancer
British Journal of Cancer
Evans TRJ, Pentheroudakis G, Paul J, McInnes A, Blackie R, Raby N, Morrison R, Fullarton GM, Soukop M, McDonald AC. Phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma
Annals of Oncology
DeBono JS, Dalgleish AG, Carmichael J, Diffley J, Lofts FJ, Fyffe D, Ellard S, Gordon RJ, Brindley CR, Evans TRJ. A phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide
Clinical Cancer Research
Dr. T. R. Jeffry Evans
Dirección profesional:
Garscu be Estate. Switchback Road. Glasgow G61 1BD. Reino Unido
|
